UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-40737

 

 

AFTERNEXT HEALTHTECH ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

 

301 Commerce Street, Suite 3300

Fort Worth, TX

(212) 405-8458

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Units, each consisting of one share of Class A Ordinary Shares and one-third of one Warrant Class A

Ordinary Shares, par value $0.0001 per share

Warrants, each whole warrant exercisable for one share of Class A Ordinary Shares at an exercise price of $11.50

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)		☒
Rule 12g-4(a)(2)		☐
Rule 12h-3(b)(1)(i)		☒
Rule 12h-3(b)(1)(ii)		☐
Rule 15d-6		☐
Rule 15d-22(b)		☐

Approximate number of holders of record as of the certification or notice date: None

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, AfterNext HealthTech Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

		AFTERNEXT HEALTHTECH ACQUISITION CORP.
Date: August 28, 2023		By:		/s/ Art Heidrich
				Name: Art Heidrich
				Title: Secretary